ZapE is a novel cell division protein interacting with FtsZ and modulating the Z-ring dynamics von Marteyn, B.S, Karimova, G, Fenton, A.K, Gazi, A.D, West, N, Touqui, L, Prevost, M.-C, Betton, J.-M, Poyraz, O, Ladant, D, Gerdes, K, Sansonetti, P.J, Tang, C.M

Volltext bestellen

Persistence of an atherogenic lipid profile after treatment of acute infection with brucella von Apostolou, F., Gazi, I.F., Kostoula, A., Tellis, C.C., Tselepis, A.D., Elisaf, M., Liberopoulos, E.N.

Volltext

The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A2 in obese patients with metabolic syndrome von Filippatos, T.D, Gazi, I.F, Liberopoulos, E.N, Athyros, V.G, Elisaf, M.S, Tselepis, A.D, Kiortsis, D.N

Volltext

Acute infection with Epstein–Barr virus is associated with atherogenic lipid changes von Apostolou, F, Gazi, I.F, Lagos, K, Tellis, C.C, Tselepis, A.D, Liberopoulos, E.N, Elisaf, M

Volltext

Increased plasma visfatin concentration is a marker of an atherogenic metabolic profile von Filippatos, T.D, Tsimihodimos, V, Derdemezis, C.S, Gazi, I.F, Saougos, V, Mikhailidis, D.P, Tselepis, A.D, Elisaf, M.S

Volltext

effects of orlistat and fenofibrate, alone or in combination, on high-density lipoprotein subfractions and pre-beta1-HDL levels in obese patients with metabolic syndrome von Filippatos, T.D, Liberopoulos, E.N, Kostapanos, M, Gazi, I.F, Papavasiliou, E.C, Kiortsis, D.N, Tselepis, A.D, Elisaf, M.S

Volltext

The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A 2 in obese patients with metabolic syndrome von Filippatos, T.D., Gazi, I.F., Liberopoulos, E.N., Athyros, V.G., Elisaf, M.S., Tselepis, A.D., Kiortsis, D.N.

Volltext

543 PLASMA VISFATIN CONCENTRATION IS A MARKER OF AN ATHEROGENIC METABOLIC PROFILE von Filippatos, T., Tsimihodimos, V., Derdemezis, C.S., Gazi, I.F., Saougos, V., Tselepis, A.D., Elisaf, M.S.

Volltext

256 EFFECT OF EZETIMIBE ON MARKERS OF OXIDATIVE STRESS IN PATIENTS WITH HYPERCHOLESTEROLEMIA von Kostapanos, M.S., Spyrou, A.T., Tellis, C.C., Gazi, I.F., Tselepis, A.D., Liberopoulos, E.N., Elisaf, M.S.

Volltext

PO3-85 EVALUATION OF THE ABILITY OF SIMPLE LIPID MEASURES TO PREDICT THE PRESENCE OF SMALL, DENSE LDL PARTICLES von Tsimihodimos, V., Gazi, I., Kalogirou, M., Tselepis, A.D., Elisaf, M.

Volltext

HIGH-DENSITY LIPOPROTEIN SUBCLASSES IN PATIENTS WITH OR WITHOUT THE METABOLIC SYNDROME von Lagos, K.G., Gazi, I.F., Kostapanos, M.S., Filippatos, T., Kazakou, P.S., Rizos, C.V., Tselepis, A.D., Elisaf, M.

Volltext

T04-P-016 Plasma PAF-Acetylhydrolase (LP-PLA2) activity as a marker of small-dense LDL in subjects at median cardiovascular risk von Filippatos, T.D., Gazi, I., Kiortsis, D.N., Elisaf, M.S., Tselepis, A.D.

Volltext

PO23-726 EFFECT OF EZETIMIBE ON LIPOPROTEIN SUBFRACTIONS IN PATIENTS WITH PRIMARY DYSLIPIDEMIAS von Kalogirou, M., Tsimihodimos, V., Gazi, I., Kostara, C., Tselepis, A.D., Elisaf, M.

Volltext

PO21-642 HYPERTRIGLYCERIDAEMIC WAIST PHENOTYPE DEFINITIONS AND PREVALENT METABOLIC TRIAD IN WOMEN von Gazi, I.F., Milionis, H.J., Filippatos, T.D., Kostapanos, M.S., Saougos, V.G., Tselepis, A.D., Elisaf, M.S.

Volltext

Th-P16:271 Effects of orlistat and fenofibrate combination on LDL phenotype in overweight and obese patients with metabolic syndrome the fenorli study von Filippatos, T.D., Kiortsis, D.N., Gazi, I., Liberopoulos, E.N., Georgoula, M., Elisaf, M.S., Tselepis, A.D.

Volltext